Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Potential Role of Sirtuins As Epigenetic Biomarkers for the Clinical Management of the Patient with Atherosclerosis or Calcific Aortic Stenosis

NCT06337227 is registered in ClinicalTrials.gov with IRCCS SYNLAB SDN as lead sponsor.

NCT NCT06337227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06337227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Potential Role of Sirtuins As Epigenetic Biomarkers for the Clinical Management of the Patient with Atherosclerosis or Calcific Aortic Stenosis
Lead sponsor
IRCCS SYNLAB SDN
Phase
Observational
Overall status
Recruiting
Start date
October 19, 2023
Completion date
October 31, 2026
Enrollment
3 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis and calcific aortic stenosis with and without diabetes